Skip to main content
Premium Trial:

Request an Annual Quote

MiTeGen, EMBLEM Sign Structural Biology Agreements

NEW YORK (GenomeWeb News) – Structural biology tools firm MiTeGen announced today it has forged development and distribution agreements with EMBLEM, the commercial subsidiary of the European Molecular Biology Laboratory.

MiTeGen and EMBL's operations in Grenoble, France, are collaborating on the further development of thin-film crystallization plates for protein crystallization. Also, MiTeGen will exclusively distribute on a worldwide basis EMBL's CrystalDirect plates as well as non-exclusively distribute other EMBL products, including the SC3 basket for cryo-storage and transport of samples, MiTeGen said.

Financial and other terms of the deal were not disclosed.

"The development of thin-film plates such as MiTeGen's In-Situ-01 plate, and EMBL's CrystalDirect Plate brings significant new capabilities to crystallographers," including the ability to perform X-ray and UV studies on crystals in situ, Robert Newman, CEO of MiTeGen, said in a statement. "The collaboration of MiTeGen and the EMBL for the further development in this arena is a great match for bringing unique advancements in these tools to the scientific community."

MiTeGen, based in Ithaca, NY, designs, manufactures, and distributes products for crystallization, crystallography, and X-ray diffraction of proteins, viruses, and small molecule and inorganic compounds, it said. Additionally, the company develops and distributes products for manipulating and measuring small samples in cell biology, histology, clinical diagnostics, entomology, archaeology, art restoration, and geology.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.